Clinical trial
Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD)
NCT00203463 · Tuscaloosa Research & Education Advancement Corporation, Other · Completed
Key facts
| NCT number | NCT00203463 |
|---|---|
| Title | Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD) |
| Official title | Topiramate in the Treatment of Post Traumatic Stress Disorder (PTSD) |
| Lead sponsor | Tuscaloosa Research & Education Advancement Corporation, Other |
| Collaborators | Ortho-McNeil Janssen Scientific Affairs, LLC Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | PTSD |
| Intervention type | Drug |
| Interventions | topiramate |
| Enrollment | 40 |
| Start date | Jul 1, 2001 |
| Primary completion | Sep 1, 2004 |
| Completion | Sep 1, 2004 |
| First posted | Sep 20, 2005 |
| Last update posted | Jul 29, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: